Also, tissue-specific genes with protein products entering the bloodstream may find applications as biomarkers (KLK3 in prostate cancer) or replacement therapies (e.g., insulin in type 1 diabetes). This evidence concerns the gene KLK3 and type 1 diabetes mellitus.